SCHW
45
2
NTRS
50
6
NWS
58
2
AMAT
42
9
EQR
33
3
CAG
53
12
PH
53
3
MOS
48
3
ADT
28
-9
AON
28
-2
AN
43
5
MAS
40
4
CMI
52
3
WDC
41
4
BSX
64
3
CMG
51
-3
SEE
45
3
ROP
33
-2
CTAS
39
3
D
50
2
SCHW
45
2
NTRS
50
6
NWS
58
2
AMAT
42
9
EQR
33
3
CAG
53
12
PH
53
3
MOS
48
3
ADT
28
-9
AON
28
-2
AN
43
5
MAS
40
4
CMI
52
3
WDC
41
4
BSX
64
3
CMG
51
-3
SEE
45
3
ROP
33
-2
CTAS
39
3
D
50
2
Financhill
Back

INmune Bio 10K Form

Sell
45

INMB
INmune Bio

Last Price:
$5.30
Seasonality Move:
-17.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INMB News And Ratings

See the #1 stock for the next 7 days that we like better than INMB

INMB Financial Statistics

Sales & Book Value

Annual Sales: $155K
Cash Flow: $-7M
Price / Cash Flow: 0
Annual Sales: $1.74
Price / Book: 3.04

Profitability

EPS (TTM): -2.18000
Net Income (TTM): $-41.3M
Gross Margin: --
Return on Equity: -79.18%
Return on Assets: -55.6%

INmune Bio Earnings Forecast

Key INmune Bio Financial Ratios

  • The Research & Development expenses have been 13,079.35% of Revenue.
  • The Net Earning history of INMB is -19,360.00% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

INmune Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INMB
CUSIP: 45782T
Website: inmunebio.com

Debt

Debt-to-Equity Ratio: 0.26
Current Ratio: 1.71
Quick Ratio: 1.64

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INMB Technical Analysis vs Fundamental Analysis

Sell
45
INmune Bio (INMB) is a Sell

Is INmune Bio a Buy or a Sell?

  • INmune Bio stock is rated a Sell
    The current INmune Bio [INMB] share price is $5.30. The Score for INMB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.